Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. All clinical decisions are made by independent licensed clinicians based on individual patient evaluation. Consult a qualified healthcare professional before starting any therapy. New Blue Health is a technology and administrative services platform, not a medical provider.

hCG and Men's Hormone Health: What It Is and How It Supports Hormonal Balance

Most men first hear about hCG in the context of pregnancy tests or weight loss fads. So when a friend, a forum post, or a clinician mentions it as part of a men's hormone protocol, the reaction is usually confusion — followed by a deep dive into contradictory information online. This article exists to cut through that noise with specifics: what hCG actually does in the male body, what the published research says, and how it fits (or doesn't fit) alongside therapies like testosterone replacement. Every clinical claim here is attributed to published data or deferred to licensed clinicians, and this content is reviewed under New Blue Health's editorial policy.

What Is hCG? A Brief Overview

Human chorionic gonadotropin (hCG) is a glycoprotein hormone composed of two subunits — alpha and beta — that shares structural similarity with luteinizing hormone (LH). While the placenta produces hCG during pregnancy, the hormone itself is not sex-specific. Its biological activity in men centers on its ability to bind LH receptors in testicular Leydig cells, stimulating endogenous testosterone production.

Commercially manufactured hCG products have been investigated in clinical settings for decades, primarily for hypogonadism and fertility preservation. After certain branded hCG products were removed from the market or became difficult to source, compounded versions prepared at state-licensed 503A pharmacies became a more commonly discussed option. Compounded hCG is prepared to order based on a clinician's prescription — it is not commercially manufactured in the same way as branded pharmaceuticals.

This distinction matters. Men searching for hCG online will encounter a patchwork of sources: research chemical sites, overseas pharmacies, and legitimate clinical pathways. Only the last category involves a licensed clinician evaluating your health profile before anything ships. If you're evaluating a provider, the compounded source verification checklist is a practical starting point.

How hCG Works in the Male Body

hCG mimics the action of LH, the pituitary hormone responsible for signaling Leydig cells to produce testosterone. When a man receives exogenous hCG, it binds to LH receptors in the testes, triggering a cascade that includes cholesterol conversion to pregnenolone and, ultimately, testosterone synthesis.

This mechanism has a specific clinical implication: hCG can stimulate intratesticular testosterone (ITT) production even when the hypothalamic-pituitary-gonadal (HPG) axis is suppressed. That suppression is exactly what happens during exogenous testosterone administration. The pituitary detects adequate circulating testosterone and reduces LH output, which in turn reduces the testes' own production. Over time, this can lead to testicular atrophy and reduced spermatogenesis.

hCG sidesteps the pituitary entirely. By acting directly on LH receptors, it maintains a degree of testicular stimulation that exogenous testosterone alone does not provide. This is why hCG is frequently discussed alongside testosterone replacement therapy (TRT) — not as a replacement for testosterone, but as a complementary agent that may help preserve testicular volume and function.

One clarification worth making: hCG does not "boost" testosterone in the way supplements claim to. It activates a specific receptor pathway. The magnitude and clinical significance of that activation depend on individual physiology, Leydig cell responsiveness, and dosing — all of which require clinical evaluation.

hCG's Supportive Role Alongside TRT and Other Therapies

Men on TRT often face a trade-off. Exogenous testosterone addresses low-T symptoms — fatigue, reduced libido, loss of lean mass — but it suppresses the HPG axis. The downstream effects include decreased sperm production and, in many cases, measurable testicular shrinkage. For men who want the symptomatic benefits of TRT without fully shutting down endogenous function, hCG has been used as a concurrent therapy.

Coviello et al. (2008) published a study in The Journal of Clinical Endocrinology & Metabolism examining the effects of low-dose hCG co-administered with exogenous testosterone in healthy men. They found that hCG maintained intratesticular testosterone levels in a dose-dependent manner, even while exogenous testosterone suppressed LH. The 250 IU dose preserved ITT at roughly baseline levels, while higher doses increased it above baseline.

This finding is clinically relevant for two groups in particular: men on TRT who wish to preserve fertility potential, and men concerned about testicular atrophy as a side effect of long-term testosterone use. A licensed clinician evaluating a patient's goals — whether those include future fertility, symptom management, or both — may consider hCG as part of a broader protocol.

New Blue Health facilitates access to testosterone + hCG support protocols through its platform, connecting patients with independent licensed clinicians who evaluate whether combination therapy is appropriate based on individual health profiles.

It's also worth noting that hCG is sometimes discussed alongside other compounds like enclomiphene, which works at the pituitary level rather than directly on the testes. These are mechanistically distinct approaches, and a clinician may recommend one, both, or neither depending on the patient's lab work and clinical picture.

What the Research Says: Key Studies on hCG in Men

The evidence base for hCG in men is not as large as for testosterone itself, but several studies provide meaningful data points.

Coviello et al. (2008): As noted above, this study demonstrated dose-dependent maintenance of intratesticular testosterone during exogenous testosterone administration. It remains one of the most cited references for hCG co-therapy during TRT.

Hsieh et al. (2013): Published in The Journal of Urology, this retrospective analysis examined men on TRT who received concurrent low-dose hCG. The authors reported that hCG co-administration helped maintain semen parameters in a subset of patients, though results varied. The study underscored that hCG is not a guarantee of fertility preservation — individual response differs.

Lee and Ramasamy (2018): A review in Translational Andrology and Urology summarized the role of hCG in male hypogonadism and fertility. The authors noted that while hCG monotherapy can raise serum testosterone levels in men with secondary hypogonadism, its primary clinical utility in the TRT context is as an adjunctive agent for testicular function preservation.

Kohn et al. (2019): This paper in Current Urology Reports reviewed strategies for maintaining fertility during TRT, identifying hCG as one of the most commonly used adjuncts. The authors recommended that clinicians discuss fertility goals with patients before initiating TRT and consider hCG co-therapy proactively rather than reactively.

None of these studies suggest hCG is appropriate for every man, and none describe it as a standalone replacement for TRT in men with primary hypogonadism. The research supports a specific, adjunctive role — and that nuance tends to get lost in online forums.

Who Might Explore hCG? Common Considerations

Not every man on testosterone therapy needs hCG, and not every man who asks about it will be a candidate. Some common scenarios where clinicians may evaluate hCG include:

• Men on TRT who want to preserve fertility. Exogenous testosterone suppresses spermatogenesis. hCG may partially counteract this suppression by maintaining intratesticular testosterone levels.
• Men experiencing testicular atrophy on TRT. Shrinkage is a common side effect of HPG axis suppression. hCG can help maintain testicular volume.
• Men with secondary hypogonadism exploring alternatives to TRT. In cases where the issue is pituitary signaling rather than testicular failure, hCG monotherapy has been investigated as a way to stimulate endogenous production.
• Men transitioning off TRT. Some clinicians use hCG as part of a protocol to help restart endogenous testosterone production, though evidence here is more limited and protocols vary.

Eligibility depends on clinical review. Lab work — including total and free testosterone, LH, FSH, estradiol, and semen analysis where relevant — informs the decision. A licensed clinician evaluates the full picture before prescribing anything.

Potential Side Effects and Safety Considerations

hCG is not without risks. Because it stimulates testosterone production, it can also increase estradiol levels via aromatization. Elevated estradiol may cause symptoms like water retention, mood changes, or gynecomastia in some men. Clinicians often monitor estradiol levels in patients receiving hCG and may adjust protocols accordingly.

Other reported side effects include injection site reactions, headache, and fatigue. Rare but serious adverse events — including overstimulation syndrome (more relevant in female fertility contexts) — are documented in the literature, though they are uncommon at the doses typically discussed for male hormone support.

Long-term safety data on hCG use in men is limited compared to testosterone itself. This is another reason clinical oversight matters. Self-administering hCG obtained from unregulated sources carries risks beyond side effects: contamination, incorrect concentration, and lack of clinical monitoring among them. The guide on evaluating peptide and telehealth providers covers what to look for — and what to avoid — when sourcing any clinician-guided therapy.

Compounded hCG: What You Should Know

After certain branded hCG products became less available, compounded hCG emerged as the primary access point for many patients. Compounded medications are prepared at state-licensed 503A pharmacies based on a clinician's prescription. They are not commercially manufactured, and they are not equivalent to branded products in terms of regulatory pathway.

This does not mean compounded hCG is unregulated. 503A pharmacies operate under state boards of pharmacy and must comply with USP compounding standards. However, the oversight structure differs from that of commercially manufactured drugs. Patients should verify that their medication comes from a licensed compounding pharmacy — not a research chemical vendor or overseas source.

New Blue Health's compounding disclosure explains how medications are sourced and fulfilled through its platform. The platform itself is LegitScript-certified, which involves third-party verification of compliance with applicable laws and regulations.

How Telehealth Platforms Support Access to Clinician-Guided Care

Telehealth has changed how men access hormone-related therapies. Rather than waiting weeks for an in-person endocrinology appointment — or, worse, self-treating with products purchased from unverified sources — platforms like New Blue Health facilitate a structured process: intake, clinical review by an independent licensed clinician, and (if appropriate) pharmacy fulfillment.

New Blue Health is a technology and administrative services platform, not a medical provider. It coordinates the administrative and logistical steps so that patients can connect with licensed clinicians who make independent prescribing decisions. The platform offers a testosterone + hCG support pathway where all-in pricing includes the clinical consultation, prescription (if prescribed), medication, supplies, and shipping. The price is all-in, with the clinical consultation included.

Service is available in 48 states (Alabama and Mississippi excluded). You can review state-specific availability at [[newbluehealth.comState Availability](http://newbluehealth.com/state-availability)](https://newbluehealth.com/state-availability).

Andy Palenzuela, who founded New Blue Health after 14+ years in regulated health product supply chains, built the platform around a specific frustration: men were either overpaying for basic clinical access or bypassing clinical oversight entirely. The platform's structure — LegitScript-certified, clinician-reviewed, pharmacy-fulfilled — is designed to sit between those two extremes.

Key Takeaways and Next Steps

hCG is a hormone with a specific, well-studied mechanism of action in men: it binds LH receptors in the testes and stimulates endogenous testosterone production. Its primary clinical role is adjunctive — supporting testicular function and fertility potential alongside TRT, not replacing testosterone therapy outright.

The research supports its use in defined clinical scenarios, but individual eligibility depends on lab work, health history, and a clinician's assessment. Compounded hCG is available through state-licensed 503A pharmacies and can be accessed via telehealth platforms that include clinical review in their process.

If you're considering hCG as part of a hormone support plan, the next step is a clinical evaluation — not a purchase from an unverified source.

Frequently Asked Questions

What is hCG and how does it relate to men's hormone health?

hCG (human chorionic gonadotropin) is a hormone that mimics luteinizing hormone (LH) in the body. In men, it may support the testes in producing testosterone and maintaining testicular function, and it is sometimes discussed alongside testosterone replacement therapy. A licensed clinician can help determine whether hCG is appropriate for your individual health profile.

What is the regulatory status of compounded hCG?

Compounded hCG is prepared at state-licensed 503A compounding pharmacies and is not commercially manufactured. Compounding pharmacies create medications tailored to a clinician's prescription. If appropriate, a licensed clinician may prescribe compounded hCG as part of a broader care plan.

Can I get hCG through a telehealth platform like New Blue Health?

New Blue Health is a technology and administrative services platform that facilitates patient intake and care coordination with independent licensed clinicians. Eligibility for any therapy, including hCG, depends on clinical review. If a clinician determines hCG is appropriate, the pharmacy ships directly to you. Service is available in 48 states (Alabama and Mississippi excluded), subject to pathway and state availability.

Does everyone who applies for hCG get approved?

No. Eligibility depends on clinical review by an independent licensed clinician. Not everyone qualifies. The clinician evaluates your health history, goals, and medical profile before making any prescribing decision.

What happens if a clinician determines hCG is not right for me?

If an independent licensed clinician determines hCG is not appropriate for you, no prescription is issued and you receive a refund of your payment minus the $75 clinical consultation fee, which covers the completed clinical review. The listed price is all-in — the consultation is included and is never a separate charge on top of the listed price.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. All clinical decisions are made by independent licensed clinicians based on individual patient evaluation. New Blue Health is a technology and administrative services platform, not a medical provider. Individual results vary, and no specific outcomes can be promised. Consult a qualified healthcare professional before making decisions about your health.

Written by Andy Palenzuela — founder of New Blue Health, with 14+ years in regulated health product supply chains. Clinical content reviewed by the New Blue Health Clinical Content Team.